Acute Stroke Care Is at Risk in the Era of COVID-19: Experience at a Comprehensive Stroke Center in Barcelona.


Journal

Stroke
ISSN: 1524-4628
Titre abrégé: Stroke
Pays: United States
ID NLM: 0235266

Informations de publication

Date de publication:
07 2020
Historique:
pubmed: 23 5 2020
medline: 7 7 2020
entrez: 23 5 2020
Statut: ppublish

Résumé

The purpose of the study is to analyze how the coronavirus disease 2019 (COVID-19) pandemic affected acute stroke care in a Comprehensive Stroke Center. On February 28, 2020, contingency plans were implemented at Hospital Clinic of Barcelona to contain the COVID-19 pandemic. Among them, the decision to refrain from reallocating the Stroke Team and Stroke Unit to the care of patients with COVID-19. From March 1 to March 31, 2020, we measured the number of emergency calls to the Emergency Medical System in Catalonia (7.5 million inhabitants), and the Stroke Codes dispatched to Hospital Clinic of Barcelona. We recorded all stroke admissions, and the adequacy of acute care measures, including the number of thrombectomies, workflow metrics, angiographic results, and clinical outcomes. Data were compared with March 2019 using parametric or nonparametric methods as appropriate. At Hospital Clinic of Barcelona, 1232 patients with COVID-19 were admitted in March 2020, demanding 60% of the hospital bed capacity. Relative to March 2019, the Emergency Medical System had a 330% mean increment in the number of calls (158 005 versus 679 569), but fewer Stroke Code activations (517 versus 426). Stroke admissions (108 versus 83) and the number of thrombectomies (21 versus 16) declined at Hospital Clinic of Barcelona, particularly after lockdown of the population. Younger age was found in stroke admissions during the pandemic (median [interquartile range] 69 [64-73] versus 75 [73-80] years, The COVID-19 pandemic reduced by a quarter the stroke admissions and thrombectomies performed at a Comprehensive Stroke Center but did not affect the quality of care metrics. During the lockdown, there was an overload of emergency calls but fewer Stroke Code activations, particularly in elderly patients. Hospital contingency plans, patient transport systems, and population-targeted alerts must act concertedly to better protect the chain of stroke care in times of pandemic.

Sections du résumé

BACKGROUND AND PURPOSE
The purpose of the study is to analyze how the coronavirus disease 2019 (COVID-19) pandemic affected acute stroke care in a Comprehensive Stroke Center.
METHODS
On February 28, 2020, contingency plans were implemented at Hospital Clinic of Barcelona to contain the COVID-19 pandemic. Among them, the decision to refrain from reallocating the Stroke Team and Stroke Unit to the care of patients with COVID-19. From March 1 to March 31, 2020, we measured the number of emergency calls to the Emergency Medical System in Catalonia (7.5 million inhabitants), and the Stroke Codes dispatched to Hospital Clinic of Barcelona. We recorded all stroke admissions, and the adequacy of acute care measures, including the number of thrombectomies, workflow metrics, angiographic results, and clinical outcomes. Data were compared with March 2019 using parametric or nonparametric methods as appropriate.
RESULTS
At Hospital Clinic of Barcelona, 1232 patients with COVID-19 were admitted in March 2020, demanding 60% of the hospital bed capacity. Relative to March 2019, the Emergency Medical System had a 330% mean increment in the number of calls (158 005 versus 679 569), but fewer Stroke Code activations (517 versus 426). Stroke admissions (108 versus 83) and the number of thrombectomies (21 versus 16) declined at Hospital Clinic of Barcelona, particularly after lockdown of the population. Younger age was found in stroke admissions during the pandemic (median [interquartile range] 69 [64-73] versus 75 [73-80] years,
CONCLUSIONS
The COVID-19 pandemic reduced by a quarter the stroke admissions and thrombectomies performed at a Comprehensive Stroke Center but did not affect the quality of care metrics. During the lockdown, there was an overload of emergency calls but fewer Stroke Code activations, particularly in elderly patients. Hospital contingency plans, patient transport systems, and population-targeted alerts must act concertedly to better protect the chain of stroke care in times of pandemic.

Identifiants

pubmed: 32438895
doi: 10.1161/STROKEAHA.120.030329
pmc: PMC7258755
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1991-1995

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Références

Neurology. 2020 May 12;94(19):809-810
pubmed: 32229625
Int J Stroke. 2021 Jan;16(1):110-116
pubmed: 31852410
JAMA. 2020 May 26;323(20):2005-2006
pubmed: 32282023
BMJ. 2020 Mar 12;368:m1036
pubmed: 32165426
Ann Intern Med. 2020 Jul 7;173(1):21-28
pubmed: 32259197
Stroke. 2018 Mar;49(3):e46-e110
pubmed: 29367334
Stroke. 2011 Jul;42(7):2001-6
pubmed: 21566237
Health Soc Care Community. 2018 Mar;26(2):147-157
pubmed: 27413007
Stroke. 2020 Jun;51(6):1891-1895
pubmed: 32233980
Circ Cardiovasc Qual Outcomes. 2020 Apr;13(4):e006631
pubmed: 32182131
Stroke. 2020 May;51(5):1356-1357
pubmed: 32228369
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Neurol Sci. 2020 May;41(5):1003-1005
pubmed: 32270359
Int J Stroke. 2020 Jul;15(5):555-564
pubmed: 32223543

Auteurs

Salvatore Rudilosso (S)

Comprehensive Stroke Center, Department of Neuroscience, Hospital Clinic, University of Barcelona and August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Spain (S.R., C.L., V.V., M.V., A.R., L.L., V.O., S.A., X.U., Á.C.).

Carlos Laredo (C)

Comprehensive Stroke Center, Department of Neuroscience, Hospital Clinic, University of Barcelona and August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Spain (S.R., C.L., V.V., M.V., A.R., L.L., V.O., S.A., X.U., Á.C.).

Víctor Vera (V)

Comprehensive Stroke Center, Department of Neuroscience, Hospital Clinic, University of Barcelona and August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Spain (S.R., C.L., V.V., M.V., A.R., L.L., V.O., S.A., X.U., Á.C.).

Martha Vargas (M)

Comprehensive Stroke Center, Department of Neuroscience, Hospital Clinic, University of Barcelona and August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Spain (S.R., C.L., V.V., M.V., A.R., L.L., V.O., S.A., X.U., Á.C.).

Arturo Renú (A)

Comprehensive Stroke Center, Department of Neuroscience, Hospital Clinic, University of Barcelona and August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Spain (S.R., C.L., V.V., M.V., A.R., L.L., V.O., S.A., X.U., Á.C.).

Laura Llull (L)

Comprehensive Stroke Center, Department of Neuroscience, Hospital Clinic, University of Barcelona and August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Spain (S.R., C.L., V.V., M.V., A.R., L.L., V.O., S.A., X.U., Á.C.).

Víctor Obach (V)

Comprehensive Stroke Center, Department of Neuroscience, Hospital Clinic, University of Barcelona and August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Spain (S.R., C.L., V.V., M.V., A.R., L.L., V.O., S.A., X.U., Á.C.).

Sergio Amaro (S)

Comprehensive Stroke Center, Department of Neuroscience, Hospital Clinic, University of Barcelona and August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Spain (S.R., C.L., V.V., M.V., A.R., L.L., V.O., S.A., X.U., Á.C.).

Xabier Urra (X)

Comprehensive Stroke Center, Department of Neuroscience, Hospital Clinic, University of Barcelona and August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Spain (S.R., C.L., V.V., M.V., A.R., L.L., V.O., S.A., X.U., Á.C.).

Ferrán Torres (F)

Biostatistics Unit, Autonomous University of Barcelona, Spain (F.T.).

Francesc Xavier Jiménez-Fàbrega (FX)

Sistema d'Emergències Mèdiques, Barcelona, Spain (F.X.J.-F.).

Ángel Chamorro (Á)

Comprehensive Stroke Center, Department of Neuroscience, Hospital Clinic, University of Barcelona and August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Spain (S.R., C.L., V.V., M.V., A.R., L.L., V.O., S.A., X.U., Á.C.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH